TAKEDA PHARMACEUTICALS AMERICA INC - BPA FOR CINRYZE, KALBITOR, TAKHZYRO, ELAPRASE, VPRIV, FIRAZYR, ADZYNMA, LIVTENCITY, AND GATTEX.
Key Details
Description
BPA FOR CINRYZE, KALBITOR, TAKHZYRO, ELAPRASE, VPRIV, FIRAZYR, ADZYNMA, LIVTENCITY, AND GATTEX.
Context & Analysis
On Oct 30, 2025, Department of Veterans Affairs to TAKEDA PHARMACEUTICALS AMERICA INC for bpa for cinryze, kalbitor, takhzyro, elaprase, vpriv, firazyr, adzynma, livtencity, and gattex.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.